Literature DB >> 23565996

Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.

Kenichi A Tanaka, Michael A Mazzeffi, Matthias Grube, Satoru Ogawa, Edward P Chen.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23565996     DOI: 10.1111/trf.12110

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  8 in total

1.  Three-factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis.

Authors:  Nazish K Hashmi; Kamrouz Ghadimi; Amudan J Srinivasan; Yi-Ju Li; Robert D Raiff; Jeffrey G Gaca; Adam G Root; Yaron D Barac; Thomas L Ortel; Jerrold H Levy; Ian J Welsby
Journal:  Vox Sang       Date:  2019-04-02       Impact factor: 2.144

Review 2.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

3.  Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery.

Authors:  Kenichi A Tanaka; Michael A Mazzeffi; Erik R Strauss; Fania Szlam; Nina A Guzzetta
Journal:  J Anesth       Date:  2016-01-09       Impact factor: 2.078

Review 4.  Role of prothrombin complex concentrate in perioperative coagulation therapy.

Authors:  Kenichi A Tanaka; Michael Mazzeffi; Miroslav Durila
Journal:  J Intensive Care       Date:  2014-10-29

5.  Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.

Authors:  Charles L Percy; Rudolf Hartmann; Rhidian M Jones; Subramaniam Balachandran; Dheeraj Mehta; Michael Dockal; Friedrich Scheiflinger; Valerie B O'Donnell; Judith E Hall; Peter W Collins
Journal:  Blood Coagul Fibrinolysis       Date:  2015-06       Impact factor: 1.276

6.  A pragmatic pilot phase II randomised controlled trial of prothrombin complex concentrates (PCC) versus fresh frozen plasma (FFP) in adult patients who are undergoing heart surgery (PROPHESY).

Authors:  Laura Green; Neil Roberts; Jackie Cooper; Jane Field; Ravi Gill; Andrew Klein; Seema Agarwal; Simon Stanworth; Atholl Johnston; Vivienne Monk; Ben O'Brien
Journal:  Trials       Date:  2019-12-09       Impact factor: 2.279

Review 7.  Effectiveness of prothrombin complex concentrate for the treatment of bleeding: A systematic review and meta-analysis.

Authors:  Daan P van den Brink; Mathijs R Wirtz; Ary Serpa Neto; Herbert Schöchl; Victor Viersen; Jan Binnekade; Nicole P Juffermans
Journal:  J Thromb Haemost       Date:  2020-08-02       Impact factor: 5.824

8.  Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery.

Authors:  Giangiuseppe Cappabianca; Giovanni Mariscalco; Fausto Biancari; Daniele Maselli; Francesca Papesso; Marzia Cottini; Sandro Crosta; Simona Banescu; Aamer B Ahmed; Cesare Beghi
Journal:  Crit Care       Date:  2016-01-06       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.